We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,255

Global intellectual property newsletter - issue 0115
  • Clifford Chance LLP
  • China, European Union, Germany, Poland, Spain, United Kingdom, USA
  • January 21 2015

Establishment of the Unified European Patent Litigation System has been subject to many efforts of European leaders and legislators for more than four


International news: focus on compliance - winter 2014
  • McDermott Will & Emery
  • China, European Union, Germany, Global, USA
  • December 2 2014

As regulatory oversight of companiesfrom Sarbanes Oxley and the Dodd-Frank Act to the Foreign Corrupt Practices Act (FCPA) and the UK Bribery


Africa update - November 6, 2014
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • Africa, European Union, Global, USA
  • November 6 2014

On October 29th, the U.S. Agency for International Development (USAID) issued a new fact sheet on the Ebola outbreak. The fact sheet highlighted the


Food, dietary supplement & cosmetics regulatory update, vol. II, issue 5
  • Jones Day
  • European Union, United Kingdom, USA
  • March 5 2015

The Dietary Guidelines Advisory Committee ("DGAC") recently released the Scientific Report of the 2015 Dietary Guidelines for Americans (the "Advisory


Pharmaceutical & medical device regulatory update, vol. II, issue 8
  • Jones Day
  • European Union, USA
  • April 24 2015

The first U.S. biosimilar product Zarxio overcame another legal challenge earlier this month when a federal court in California denied a motion to


European study finds moderate caffeine use safe
  • Morgan Lewis & Bockius LLP
  • European Union, USA
  • February 11 2015

Confirming what coffee and tea connoisseurs have long known, the European Food Safety Authority (EFSA) in January declared that 400mg of caffeine per


Antitrust enforcement in the medical device sector - ten areas of focus in 2015
  • Sidley Austin LLP
  • China, European Union, USA
  • February 18 2015

Enforcement agencies and courts in the United States and Europe have long dealt with high-profile antitrust cases in the pharmaceutical sector


Canada: transparency of dealings between pharmaceutical companies and healthcare professionals
  • Norton Rose Fulbright LLP
  • Canada, European Union, France, USA
  • October 30 2013

Several countries have recently introduced legislation andor industry codes promoting the transparency of payments by pharmaceutical manufacturers


The antidote - September 2014
  • CMS Cameron McKenna
  • European Union, United Kingdom, USA
  • September 9 2014

Summer is nearly at an end and whilst corporate activity continued apace, including AbbVie acquiring Shire, Omega Pharma attracting acquisition


US and European approaches to antibody patents
  • FB Rice
  • European Union, USA
  • June 13 2013

When monoclonal antibodies were first produced in 1974, Kohler and Milstein predicted that they “could be valuable for medical and industrial use”